LIFECORE BIOMEDICAL, INC.: current accounts payable
Current accounts payable for LIFECORE BIOMEDICAL, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All LIFECORE BIOMEDICAL, INC. financial histories
What this measure means
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
Exact concept: us-gaap:AccountsPayableCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2011-05-29 to 2025-05-25. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-05-25 | 8,220,000 | USD | 2025-08-07 | 10-K · 0001005286-25-000108 |
| At date | 2024-05-26 | 16,334,000 | USD | 2025-08-07 | 10-K · 0001005286-25-000108 |
| At date | 2023-05-28 | 22,097,000 | USD | 2024-08-26 | 10-K · 0001005286-24-000124 |
| At date | 2023-02-26 | 14,657,000 | USD | 2024-03-20 | 10-K · 0001005286-24-000030 |
| At date | 2022-11-27 | 13,301,000 | USD | 2024-03-20 | 10-K · 0001005286-24-000030 |
| At date | 2022-08-28 | 9,623,000 | USD | 2024-03-20 | 10-K · 0001005286-24-000030 |
| At date | 2022-05-29 | 12,952,000 | USD | 2024-03-20 | 10-K · 0001005286-24-000030 |
| At date | 2022-02-27 | 13,294,000 | USD | 2024-03-20 | 10-K · 0001005286-24-000030 |
| At date | 2021-11-28 | 8,655,000 | USD | 2024-03-20 | 10-K · 0001005286-24-000030 |
| At date | 2021-08-29 | 8,606,000 | USD | 2024-03-20 | 10-K · 0001005286-24-000030 |
| At date | 2021-05-30 | 11,622,000 | USD | 2024-03-20 | 10-K · 0001005286-24-000030 |
| At date | 2021-02-28 | 8,887,000 | USD | 2024-03-20 | 10-K · 0001005286-24-000030 |
| At date | 2020-11-29 | 7,985,000 | USD | 2024-03-20 | 10-K · 0001005286-24-000030 |
| At date | 2020-08-30 | 6,351,000 | USD | 2024-03-20 | 10-K · 0001005286-24-000030 |
| At date | 2020-05-31 | 51,647,000 | USD | 2021-07-29 | 10-K · 0001005286-21-000043 |
| At date | 2019-05-26 | 53,973,000 | USD | 2020-08-14 | 10-K · 0001005286-20-000004 |
| At date | 2018-05-27 | 34,668,000 | USD | 2019-08-01 | 10-K · 0001628280-19-009791 |
| At date | 2017-05-28 | 24,527,000 | USD | 2018-08-09 | 10-K · 0001437749-18-015135 |
| At date | 2016-05-29 | 30,904,000 | USD | 2018-03-15 | 10-K/A · 0001437749-18-004661 |
| At date | 2015-05-31 | 35,009,000 | USD | 2016-08-01 | 10-K · 0001437749-16-036012 |
| At date | 2014-05-25 | 31,981,000 | USD | 2015-07-31 | 10-K · 0001437749-15-014383 |
| At date | 2013-05-26 | 32,031,000 | USD | 2014-08-01 | 10-K · 0001437749-14-013994 |
| At date | 2012-05-27 | 22,644,000 | USD | 2013-08-07 | 10-K · 0001437749-13-010047 |
| At date | 2011-05-29 | 16,747,000 | USD | 2012-08-08 | 10-K · 0001437749-12-007975 |
Related financial histories
- LIFECORE BIOMEDICAL, INC.: total assets
- LIFECORE BIOMEDICAL, INC.: total liabilities
- LIFECORE BIOMEDICAL, INC.: stockholders equity
- LIFECORE BIOMEDICAL, INC.: cash and cash equivalents
- LIFECORE BIOMEDICAL, INC.: net income or loss
- LIFECORE BIOMEDICAL, INC.: operating cash flow
- LIFECORE BIOMEDICAL, INC.: capital expenditure payments
- LIFECORE BIOMEDICAL, INC.: revenue
- LIFECORE BIOMEDICAL, INC.: financing cash flow
- LIFECORE BIOMEDICAL, INC.: investing cash flow
- LIFECORE BIOMEDICAL, INC.: retained earnings or deficit
- LIFECORE BIOMEDICAL, INC.: basic weighted-average shares
- LIFECORE BIOMEDICAL, INC.: diluted weighted-average shares
- LIFECORE BIOMEDICAL, INC.: basic earnings per share
- LIFECORE BIOMEDICAL, INC.: diluted earnings per share
- LIFECORE BIOMEDICAL, INC.: income tax expense or benefit
- LIFECORE BIOMEDICAL, INC.: net property, plant and equipment
- LIFECORE BIOMEDICAL, INC.: share-based compensation expense
- LIFECORE BIOMEDICAL, INC.: operating income or loss
- LIFECORE BIOMEDICAL, INC.: current assets
- LIFECORE BIOMEDICAL, INC.: interest expense
- LIFECORE BIOMEDICAL, INC.: current liabilities
- LIFECORE BIOMEDICAL, INC.: goodwill carrying amount
- LIFECORE BIOMEDICAL, INC.: net finite-lived intangible assets
- LIFECORE BIOMEDICAL, INC.: net current accounts receivable
- LIFECORE BIOMEDICAL, INC.: operating expenses
- LIFECORE BIOMEDICAL, INC.: net inventory
- LIFECORE BIOMEDICAL, INC.: gross profit
- LIFECORE BIOMEDICAL, INC.: cost of revenue
- LIFECORE BIOMEDICAL, INC.: selling, general and administrative expense
- LIFECORE BIOMEDICAL, INC.: research and development expense
Inspect the source
- Entity
- LIFECORE BIOMEDICAL, INC. / CIK 0001005286
- Captured
- 2026-09-20T05:11:51.367Z
- SEC response SHA-256
1558a2ffe6e0c9b46b5ee698b0dbe287366a9808531f7c820d0d5517eb583dd6
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001005286.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))